Literature DB >> 15030123

Clinical and epidemiological features of Lyme borreliosis in Bulgaria.

Iva Christova1, Radka Komitova.   

Abstract

INTRODUCTION: Data on disease expression and epidemiological characteristics of Lyme borreliosis in south-eastern Europe are scarce. PATIENTS: To reveal features of Lyme borreliosis in Bulgaria, clinical data and epidemiological characteristics of 1257 patients reported between 1999 and 2002 were analysed.
RESULTS: The most affected age group was 5-9 years, followed by 45-49 years, 50-54 years, and 10-14 years. Most of the patients (68%) lived in a rural area or were attacked by ticks during activities in a rural area. Lyme borreliosis cases occurred throughout the year with two peaks--one in June and second smaller one in September. The most common clinical manifestation was erythema migrans (EM), diagnosed in 868 (69.1%) of the patients. Rashes had a median diameter of 11 cm and were predominantly located on lower extremities. Forty-four per cent of the rashes consisted of homogenous erythema and 56% had central clearing. Multiple EM was detected in 4.3% of the EM cases. Neuroborreliosis was the second most common presentation of Lyme borreliosis, diagnosed in 19% of the patients. Lyme arthritis was found in 8% of the patients. Heart and ocular manifestations were recorded in 1.1% and 0.9% of the patients, respectively. Borrelial lymphocytoma and acrodermatitis chronica atrophicans were very rare (0.3%). Twenty-seven patients (2.1%) had multiple organ involvement.
CONCLUSIONS: The results of the study show that the epidemiology and clinical manifestations of Lyme borreliosis in Bulgaria are similar to those in the majority European countries but possess some distinguishing characteristics.

Entities:  

Mesh:

Year:  2004        PMID: 15030123     DOI: 10.1007/BF03040423

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  27 in total

1.  Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European Community Concerted Action on Risk Assessment in Lyme Borreliosis.

Authors:  M A Cimmino
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

Review 2.  European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis.

Authors:  G Stanek; S O'Connell; M Cimmino; E Aberer; W Kristoferitsch; M Granström; E Guy; J Gray
Journal:  Wien Klin Wochenschr       Date:  1996-12-13       Impact factor: 1.704

3.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

Review 4.  Lyme disease in the United Kingdom.

Authors:  S O'Connell
Journal:  BMJ       Date:  1995-02-04

5.  Disease expression of Lyme borreliosis in northeastern France.

Authors:  D Lipsker; Y Hansmann; F Limbach; C Clerc; C Tranchant; F Grunenberger; F Caro-Sampara; P Attali; M Frey; M Kubina; Y Piémont; J Sibilia; B Jaulhac
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-04       Impact factor: 3.267

6.  Clinical and epidemiological findings for patients with erythema migrans. Comparison of cohorts from the years 1993 and 2000.

Authors:  Franc Strle; Jerneja Videcnik; Peter Zorman; Joze Cimperman; Stanka Lotric-Furlan; Vera Maraspin
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

7.  Analysis of the human antibody response to outer surface protein C (OspC) of Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii.

Authors:  M J Mathiesen; K Hansen; N Axelsen; L Halkier-Sørensen; M Theisen
Journal:  Med Microbiol Immunol       Date:  1996-11       Impact factor: 3.402

8.  Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis.

Authors:  A Le Fleche; D Postic; K Girardet; O Peter; G Baranton
Journal:  Int J Syst Bacteriol       Date:  1997-10

Review 9.  A serological survey and review of clinical Lyme borreliosis in Spain.

Authors:  P Anda; I Rodríguez; A de la Loma; M V Fernández; A Lozano
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

10.  Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens.

Authors:  M V Assous; D Postic; G Paul; P Névot; G Baranton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

View more
  8 in total

1.  Lyme borreliosis--analysis of the trends in Slovakia, 1999-2008.

Authors:  Viera Svihrova; Henrieta Hudeckova; Milos Jesenak; Katarina Schwarzova; Zina Kostanova; Ivan Ciznar
Journal:  Folia Microbiol (Praha)       Date:  2011-05-24       Impact factor: 2.099

2.  Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters.

Authors:  Emel Cetin; Mahtab Sotoudeh; Herbert Auer; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 3.  What we have learned about Lyme borreliosis from studies in children.

Authors:  Sunil K Sood
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

4.  Musculoskeletal manifestations of Lyme borreliosis - a review.

Authors:  Sebastian Udziela; Grażyna Biesiada; Magdalena Osiewicz; Mateusz Michalak; Katarzyna Stażyk; Aleksander Garlicki; Jacek Czepiel
Journal:  Arch Med Sci       Date:  2020-06-17       Impact factor: 3.707

Review 5.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

6.  Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area.

Authors:  Cees C van den Wijngaard; Agnetha Hofhuis; Mariana Simões; Ente Rood; Wilfrid van Pelt; Herve Zeller; Wim Van Bortel
Journal:  Euro Surveill       Date:  2017-07-06

7.  Acrodermatitis chronica atrophicans: various faces of the late form of Lyme borreliosis.

Authors:  Anna Moniuszko-Malinowska; Piotr Czupryna; Justyna Dunaj; Sławomir Pancewicz; Adam Garkowski; Maciej Kondrusik; Sambor Grygorczuk; Joanna Zajkowska
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

Review 8.  A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis.

Authors:  Michelle A E Brouwer; Freek R van de Schoor; Hedwig D Vrijmoeth; Mihai G Netea; Leo A B Joosten
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.